Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor

EU orphan designation number: EU/3/15/1572   
Active ingredient: Autologous T cells transduced with retroviral vector encoding an anti-CD19 CD28/CD3-zeta chimeric antigen receptor
Indication: Treatment of chronic lymphocytic leukaemia/small lymphocytic lymphoma
Sponsor: Kite Pharma EU B.V.
Science Park 408, 1098 XH Amsterdam, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/11/2015 Orphan designation EMA/OD/108/15 (2015)8022 of 11/11/2015
4/04/2017 Transfer of orphan designation EMA/OD/108/15/T/01 (2017)2288 of 3/04/2017
6/06/2017 Corrigendum (2017)2288 of 3/04/2017